PURPOSE/BACKGROUND
Tumors with microsatellite instability high/mismatch repair-deficient (MSI-H/dMMR) exhibit distinct biological features and are associated with Lynch syndrome. Current approaches for detecting MSI-H/dMMR status rely on immunohistochemistry or molecular assays. Recent advances in digital pathology hav...
L. J. Liu, R. Etzioni, Hao-Yue Zhang et al.· Clinical Cancer Research· 0 citations
PURPOSE
To evaluate the real-world comparative effectiveness of androgen receptor pathway inhibitors (ARPIs)-abiraterone, apalutamide, enzalutamide-and docetaxel, plus androgen-deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC).
METHODS
We identified US men with mHSPC who initiated ADT...
I. B. Nwogu, N. Kreif, Hiba M. Khan et al.· JCO Oncology Practice· 0 citations
PURPOSE
Conventional prognostic models for metastatic prostate cancer (mPC) typically rely on summary features like prostate-specific antigen (PSA) doubling time, often obscuring informative longitudinal dynamics. We developed TrajSurv-mPC, a flexible deep learning framework that analyzes full premetastasis patient tra...
Si-Hang Zeng, Lukas Owens, Lucas J. Liu et al.· JCO Clinical Cancer Informat...· 0 citations
A deep learning model that leverages interpretable cellular features to improve feature extraction from H&E-stained tissue sections (NEURAL-PC) and represents an extensively validated diagnostic and prognostic model for advanced prostate cancer.
Zhi-Jun Chen, Erolcan Sayar, D. Guevara et al.· JCI Insight· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.